Center for the Economics of Reproductive HealthAdministrator2024-02-21T21:28:46-05:00

The Center for the Economics of Reproductive Health

The Center for the Economics of Reproductive Health at the Institute for Women’s Policy Research (IWPR) seeks to advance public understanding and awareness of the link between access to reproductive health care services for women and their long-term economic security and well-being. We conduct original research and policy analysis at the intersections of race, ethnicity, class, and reproductive health to improve economic outcomes, and educational and employment opportunities for all women.

FL abortion ban
Florida Six-Week Abortion Ban Goes Into Effect

Thanks to the state courts and legislature, as of May 1, abortion access in Florida is now more restricted than ever under the state’s near-total ban. The impact will resonate throughout the state, harming women and hurting the state economy.  

SCOTUS mife case Mar 24
Supreme Court Known for the Overturn of Roe v. Wade Tackles Medication Abortion, but the Safety and Effectiveness of Mifepristone Is Not in Question

Access to abortion is once again before the Supreme Court as it hears arguments about mifepristone, the medication abortion drug used safely by millions of women over the last 20 years.

Dobbs anniv
“A Year After the Overturn of Roe v. Wade, We Are Only Beginning to See the Harm This Cruel Decision Is Inflicting on Women in America”

IWPR Interim President and CEO Daisy Chin-Lor on the One-Year Anniversary of the Supreme Court's decision in Dobbs

previous arrowprevious arrow
next arrownext arrow

Reproductive Health Restrictions Cost the Florida Economy Billions of Dollars Each Year–IWPR State Policy at a Glance

Laws and policies that limit access to reproductive health care have devastating and wide-ranging effects on women’s lives, families, and entire communities. These include tangible economic impacts: restricting access to reproductive health care creates barriers to women’s pursuit of education and their participation in [...]

By IWPR|October 18, 2023|

FDA Approval of First Daily Over the Counter Oral Contraceptive

This week, the FDA announced its approval for the first daily oral contraceptive in the U.S. without a prescription. After decades of scientific research on the safety, effectiveness, and overall benefits of the availability of over-the-counter contraceptives for people of all ages, the FDA’s decision [...]

By Salma Elakbawy|July 14, 2023|

“A Year After the Overturn of Roe v. Wade, We Are Only Beginning to See the Harm This Cruel Decision Is Inflicting on Women in America”

For Immediate Release June 23, 2023 Contact: William Lutz 202-785-5100 Statement of Daisy Chin-Lor, Interim President and CEO, Institute for Women’s Policy Research (IWPR) Washington, D.C. — On the one-year anniversary of the Dobbs Supreme Court decision that took away the right to safe and [...]

By William Lutz|June 23, 2023|